Medicare Enrolled
Dr. Carlos Obregon, D.O.
Pulmonary Disease · Sewell, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Obregon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Obregon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Obregon
Dr. Carlos Obregon is a pulmonary disease specialist in Sewell, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Obregon performed 2,427 Medicare services across 1,441 unique beneficiaries.
Between the years covered by Open Payments, Dr. Obregon received a total of $11,432 from 47 pharmaceutical and/or device companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Obregon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 25% volume in NJ
$11,432 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,427
Medicare services
Top 25% in NJ for pulmonary disease
1,441
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~121 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
948 | $139 | $215 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
532 | $22 | $75 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
386 | $98 | $145 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
161 | $142 | $349 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
104 | $65 | $110 |
| New patient office visit, complex (60-74 min) | 59 | $167 | $275 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
48 | $37 | $60 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
47 | $48 | $90 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
34 | $90 | $225 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
33 | $33 | $90 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
29 | $8 | $25 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
18 | $92 | $300 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
15 | $101 | $350 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
13 | $181 | $1,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,432
Total received (2018-2024)
Avg $1,633/year across 7 years
Top 12% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
733
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,291 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$141 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,375
2023
$1,686
2022
$1,829
2021
$1,642
2020
$1,410
2019
$1,310
2018
$1,181
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$868
AstraZeneca Pharmaceuticals LP
$377
GlaxoSmithKline, LLC.
$290
Regeneron Healthcare Solutions, Inc.
$190
GENZYME CORPORATION
$151
Actelion Pharmaceuticals US, Inc.
$73
Avadel CNS Pharmaceuticals, LLC
$61
ANI Pharmaceuticals, Inc.
$51
United Therapeutics Corporation
$49
Amgen Inc.
$48
HARMONY BIOSCIENCES LLC
$46
JAZZ PHARMACEUTICALS INC.
$32
Merck Sharp & Dohme LLC
$30
Insmed, Inc.
$28
Grifols USA, LLC
$23
Axsome Therapeutics, Inc.
$15
Harmony Biosciences Llc
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
Top 3 companies account for 64.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,245
GlaxoSmithKline, LLC.
$1,308
Actelion Pharmaceuticals US, Inc.
$899
INTUITIVE SURGICAL, INC.
$868
Regeneron Healthcare Solutions, Inc.
$817
GENZYME CORPORATION
$739
Genentech USA, Inc.
$415
United Therapeutics Corporation
$349
Amgen Inc.
$294
JAZZ PHARMACEUTICALS INC.
$285
Sunovion Pharmaceuticals Inc.
$282
Insmed, Inc.
$227
Bayer HealthCare Pharmaceuticals Inc.
$222
Grifols USA, LLC
$221
Philips Electronics North America Corporation
$186
Boehringer Ingelheim Pharmaceuticals, Inc.
$166
Novartis Pharmaceuticals Corporation
$159
Teva Pharmaceuticals USA, Inc.
$146
Takeda Pharmaceuticals U.S.A., Inc.
$146
Mylan Specialty L.P.
$140
Advanced Respiratory, Inc
$100
SANOFI-AVENTIS U.S. LLC
$96
Harmony Biosciences LLC
$96
Jazz Pharmaceuticals Inc.
$94
Covis Pharma GmBH
$91
HARMONY BIOSCIENCES LLC
$71
Bio Products Laboratory USA, Inc.
$62
Avadel CNS Pharmaceuticals, LLC
$61
Axsome Therapeutics, Inc.
$59
Gilead Sciences, Inc.
$59
Merck Sharp & Dohme Corporation
$56
E.R. Squibb & Sons, L.L.C.
$52
ANI Pharmaceuticals, Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$44
CSL Behring
$44
Shire North American Group Inc
$41
Boston Scientific Corporation
$34
Mallinckrodt Enterprises LLC
$31
Merck Sharp & Dohme LLC
$30
Janssen Pharmaceuticals, Inc
$29
Sun Pharmaceutical Industries Inc.
$27
Phadia US Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Harmony Biosciences Llc
$14
Paratek Pharmaceuticals, Inc.
$13
Circassia Pharmaceuticals Inc
$13
Horizon Pharma plc
$11
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · Dymista · ELIQUIS · EXALT Model D · Esbriet · FASENRA · GLASSIA · Gammaplex · HYQVIA · ILUMYA · Ilumya · ImmunoCAP · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QVAR · RAYOS · Respiratoriy Care Undiv · S&RC Und · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · XYWAV · Xembify · Xolair · Xyrem · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
253
Per 100K population
83.1
County median income
$102,807
Nearest hospital
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Obregon is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NJ), with low-engagement industry engagement in the top 12% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Obregon experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Obregon performed 948 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Obregon receive payments from pharmaceutical companies?
Yes. Dr. Obregon received a total of $11,432 from 47 companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Obregon's costs compare to other pulmonary diseases in Sewell?
Dr. Obregon's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Obregon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Sewell
Browse pulmonary diseases in Sewell ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology